Cosmetics is a prominent open-access journal published by MDPI in Switzerland, dedicated to advancing research in the fields of dermatology, pharmaceutical science, and chemical engineering, among others. Launched in 2014, this interdisciplinary journal seeks to provide a platform for the dissemination of innovative studies surrounding topical formulations, cosmetic development, and skin health, contributing to a deeper understanding of aging processes and their implications in cosmetic science. With an impressive array of quartile rankings, including Q2 placements in key categories such as Chemical Engineering and Dermatology, as well as a strong Scopus ranking showing its relevance and impact within the community, Cosmetics serves as a vital resource for researchers, professionals, and students alike. Access to its rich content is readily available through its open-access model, ensuring that breakthroughs in cosmetic science are shared widely to promote knowledge and inspire further innovation within this dynamic field.

PHARMACEUTICAL RESEARCH, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the ever-evolving field of pharmaceutical sciences. With an ISSN of 0724-8741 and an E-ISSN of 1573-904X, this journal has established itself as a critical hub for disseminating innovative research from 1984 to 2024. The journal holds impressive rankings in prominent categories, including Q2 in Biotechnology and Q2 in Pharmaceutical Science, reflecting its robust impact on the global scientific community. The journal aims to provide researchers, professionals, and students with high-quality articles that contribute significantly to the advancement of drug development and medicinal applications. Although it does not currently offer Open Access options, its rigorous peer-review process ensures that only the highest caliber research is published, making it a valuable resource for those seeking to stay at the forefront of pharmaceutical innovation.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY is a premier journal published by Taylor & Francis Ltd that focuses on the latest advancements and innovations in the field of pharmaceutical science. Established in 1996, this journal has evolved to encompass a wide array of interdisciplinary studies relevant to drug development, formulation technology, and delivery systems, serving as a platform for researchers and professionals to share groundbreaking findings. With an impressive impact factor and ranked in both Q2 in Pharmaceutical Science and Q3 in Medicine (miscellaneous), it positions itself among the top-tier journals in pharmacology and toxicology. The journal's insights are critical for scholars and practitioners aiming to enhance therapeutic efficacy and safety. Access options for the content remain traditional, thus supporting a comprehensive approach to scientific literature. Throughout its converged years up to 2024, PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY continues to play a vital role in shaping pharmaceutical education and practice.

International Journal of Dairy Technology, published by Wiley, serves as a pivotal platform for advancing research and innovation within the field of dairy science and technology. Established in 1947, this esteemed journal has garnered a significant impact factor, reflecting its influential role in disseminating critical findings and fostering discourse among professionals, researchers, and students alike. With a distinguished ranking in Q2 across several categories including Bioengineering, Food Science, and Process Chemistry and Technology, it remains integral to the academic community, demonstrating high visibility and relevance. Researchers can access a wealth of open-access content, enhancing the sharing of knowledge within the discipline. The journal’s commitment to exploring emerging trends, innovative practices, and comprehensive analyses of dairy technology ensures that it remains at the forefront of advancements in this vital area of food science and engineering.

The Journal of Aerosol Medicine and Pulmonary Drug Delivery, published by MARY ANN LIEBERT, INC, is a distinguished journal dedicated to advancing the field of aerosol medicine and pharmacology. With an ISSN of 1941-2711 and E-ISSN 1941-2703, the journal has established itself as an essential resource for researchers and professionals specializing in pharmaceutical sciences and pulmonary medicine. Ranking in the Q2 category across multiple disciplines, including Pharmaceutical Science and Pulmonary and Respiratory Medicine, it holds notable Scopus rankings, with a percentile of 78th in Pulmonary and Respiratory Medicine. The journal offers open access options, ensuring that cutting-edge research is readily available to a global audience. With converged years from 2008 to 2024, the Journal of Aerosol Medicine and Pulmonary Drug Delivery continues to serve as a vital platform for disseminating innovative research findings, clinical practice insights, and technological advancements in drug delivery systems, thereby significantly impacting therapeutic strategies for respiratory diseases.

PACKAGING TECHNOLOGY AND SCIENCE, published by Wiley, is a leading journal in the fields of packaging technology, materials science, and mechanical engineering. With a dedicated focus on innovative research and advancements in packaging materials and methodologies, the journal has made significant contributions since its inception in 1988. It holds a distinguished position as a Q2 journal in multiple disciplines, including Chemistry, Materials Science, and Mechanical Engineering, reflecting its high impact and scholarly influence. Although not an Open Access publication, it reaches a broad audience through its rigorous peer-review process and commitment to disseminating critical findings in packaging research. Researchers, professionals, and students alike benefit from the journal’s rich content that encourages interdisciplinary collaboration and the exploration of sustainable packaging solutions. For those seeking to remain at the forefront of packaging technology and science, this journal serves as an essential resource for fostering innovation and addressing the evolving challenges within the industry.

CHROMATOGRAPHIA is a renowned scholarly journal published by Springer Heidelberg, specializing in the field of analytical chemistry, biochemistry, and organic chemistry since its inception in 1968. With its ISSN 0009-5893 and E-ISSN 1612-1112, the journal has maintained a robust profile, currently ranking in the Q3 and Q4 quartiles within significant Chemistry categories. Aimed at researchers, professionals, and students, CHROMATOGRAPHIA serves as a critical platform for disseminating innovative research, methodologies, and advancements related to chromatography and its applications in various scientific fields. While the journal is not open access, it offers significant visibility and scholarly contribution opportunities, making it an essential resource for those engaged in the vibrant intersection of chemistry and biochemistry.

Journal of Cosmetic Dermatology, published by WILEY, stands as an influential platform in the field of dermatology, specifically focusing on cosmetic interventions and skin health. With its ISSN 1473-2130 and E-ISSN 1473-2165, this journal caters to a global audience, offering high-quality research and reviews that bridge the gap between scientific innovation and clinical practice. Ranked in the 74th percentile within the dermatology field, the journal occupies a notable position at Q2 in category rankings, reflecting its commitment to excellence and relevance in the cosmetic dermatology landscape. The journal encourages submissions that advance the knowledge of skin conditions, designs of cosmetic treatments, and patient care strategies, providing both researchers and practicing dermatologists with the insights needed to enhance clinical outcomes. Despite being a subscription-based platform, readers can engage deeply with a wealth of scholarly articles from 2002 through the present, which underscores its longstanding contribution to dermatological science.

Journal of Drugs in Dermatology, an esteemed publication in the field of dermatology, serves as a vital resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge and practices in skin-related therapies and treatments. Established in 2002 and published in the United States, this journal focuses on a wide range of topics pertinent to dermatological pharmacology and therapeutics, reflecting contemporary scientific advancements and innovative approaches to patient care. With a strong presence in Scopus rankings, situating it at rank #73 within the dermatology category, and achieving a commendable Q2 quartile classification in both dermatology and general medicine categories, the journal is committed to enhancing understanding of drug efficacy and safety in dermatological conditions. While the journal maintains a traditional access model, its impact factor underscores its significance in the research community, supporting the ongoing dialogue between academia and clinical practice. We invite professionals and students alike to explore the latest findings and contribute to the progressive discourse on dermatological treatments through this important publication.

The Journal of Drug Delivery Science and Technology, published by Elsevier, stands at the forefront of pharmaceutical research, focusing on innovative drug delivery systems and technologies. With a robust impact factor reflected in its Q1 rating within the pharmaceutical sciences category, this journal is recognized for its high-quality contributions, ranking #30 out of 183 in the Scopus pharmacology and toxicology category (2023). Since its inception in 2004, the journal has been pivotal in disseminating groundbreaking research and advancements in drug formulation and delivery methodologies. Researchers and practitioners alike benefit from its comprehensive articles, which are accessible under open access options, ensuring widespread dissemination of knowledge. As it converges towards its 20th anniversary in 2024, the journal continues to enhance its impact on the scientific community, paving the way for future innovations in drug delivery.